Skip to content
Assyro AI
FDA Orange Book · active-ingredient family

Mecamylamine hydrochloride

Mecamylamine hydrochloride: 1 brand, 1 generic; first approved Mar 19, 2013; generic available.

Generic availableHas discontinued products
Generic status & protection

Generic available: 1 ANDA application approved.

Brands (NDA)
1
Generics (ANDA)
1
Listed patents
0
Presentations
2

Brand (NDA) products

Originator applications
Ask AI
  • NDA 010251-
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    2.5MGTABLETORALDiscontinued-

Generic (ANDA) products (1)

Abbreviated applications
Ask AI
  • MECAMYLAMINE HYDROCHLORIDERS
    ANDA 2040542013
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    2.5MGTABLETORALRx-

Listed patents

Orange Book patent file

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Approval history

FDA approval span
Ask AI
First approval
13 yr 10 mo ago
Most recent approval
13 yr 10 mo ago

All 2 applications were approved in 2013.

Brand (NDA) 150%
Generic (ANDA) 150%

Mecamylamine hydrochloride: frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Built directly from the FDA Orange Book data file (products, patents, and exclusivity). TE codes, RLD/RS flags, patent expirations, and exclusivity dates match the official FDA record. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Related FDA reference tools

Assyro Intelligence

Ask anything about Mecamylamine hydrochloride

Cited answers from FDA, EMA, Health Canada, PubMed and ClinicalTrials.gov, in seconds. Free, no sign-up.

  • PubMed
  • ClinicalTrials.gov
  • FDA
  • Health Canada
  • EMA
  • ICH

Evaluating for a team? Book a demo